A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Clinical trial NCT06213831 · COMPLETED

Trial details

NCT number: NCT06213831
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Prurigo Nodularis

Start date: 2024-02-27
Primary completion: 2025-07-17
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.